New research fails to support efficacy of desvenlafaxine for treating MDD in adolescents

(Mary Ann Liebert, Inc./Genetic Engineering News) New studies in children and adolescents with major depressive disorder (MDD) reported negative outcomes, failing to support the effectiveness of desvenlafaxine (Pristiq, Pfizer) compared to placebo.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news